Skip to main content

I mainlined a bag of liquid vitamins — for science

doctor and iv drip
Getty Images

The image of an intravenous (IV) bag is a symbol of sickness, but healthy people across the country are signing up for the kind of IV drips typically saved for patients stuck in hospital beds. Known as nutrient IV therapy, the treatment entails pumping vitamins, minerals, and fluids directly into the bloodstream, bypassing the gastro-intestinal (GI) tract for what is meant to be a rush of wellness to the veins.

Its proponents say nutrient IVs can help ease stress, improve moods, and combat the common cold. Jet-setting celebrities have sworn by the energy boost they get from these vitamin-rich drips. Party crowds claim it all but cures a hangover.

Recommended Videos

But many experts are skeptical. A lack of published studies about the impact of nutrient drips on otherwise healthy individuals has relegated the treatment to the camp of alternative medicines, which are often rebuffed as pseudoscience. Critics have labeled nutrient IV therapy a modern-day snake oil and accuse its practitioners of being more interested in sales than science.

“It’s not an accident that we’re beautifully adapted to get nutrients through our GI tract.”

“There is a terrible paucity of data [to support the treatment],” Dr. David Katz, director of the Prevention Research Center at Yale University and author of one of the only peer-reviewed nutrient IV studies, told Digital Trends.

Let’s go for a drip

On a recent Thursday, while I was cruising on the mild type of hangover that makes everyday tasks marginally more tedious, I entered a nutrient IV clinic called the Biostation in a bougie resort in Boca Raton, Florida to get my first drip.

nutrient IV Therapy
Dyllan Furness/Digital Trends

I’d signed up to receive an infusion that contained the Myers’ cocktail, a blend of calcium, magnesium, B vitamins, and vitamin C, which was first developed by physician John Myers in the early 1960s. But flooding the bloodstream with excess minerals can be dangerous. The staff would need to run a blood sample before administering the treatment to make sure it wouldn’t overwhelm my body, so they recommended I get a less complex dose of B and C vitamins instead.

“B vitamins act as catalysts in your body,” said Dany Schaper, a registered nurse and the director of clinical services at the Biostation. Schaper said many of her patients report feeling energized by B vitamins. “They’re also very good at preventing infections and for your brain functions.” Vitamin C, meanwhile, acts as an antioxidant and boost to the immune system.

The procedure for getting a nutrient drip is a lot like donating blood, just in reverse. To get the vitamins from the IV bag into my bloodstream, Schaper injected a sizable needle into a vein in my arm. A small catheter dangled from the end of the needle like a lizard’s tail. She taped the catheter to my forearm, before I was shepherded to a cushy reclining chair in a room that might be best described as “medical chic.” A cogent sense of calm stood in for a hospital room’s perennial din and commotion.

IVs are the quickest way to get medications, nutrients, and fluids into body. As opposed to injections and infusions, ingestion requires things to travel through the GI tract, where they’re processed for absorption. IV skips that step. That’s one reason why nutrient IV practitioners support the treatment — by sidestepping the GI tract, they claim nutrient IV delivers higher, purer, and more accessible concentrations of nutrients to the body.

“The problem I have with this whole space is that the marketing seems to be way out ahead of anything the science would justify.”

But our bodies are built to process nutrients through our GI tract, said Katz. “We are a product of [between] two million and six million years or more of evolutionary biology. It’s not an accident that we’re beautifully adapted to get nutrients through our GI tract.”

Granted, the system breaks down from time to time, in which case IV treatments are vital. “But there needs to be a good reason to use routes other than the GI tract,” he said.

While nutrient IV therapy is just one part of the Biostation’s offerings (the company also provides things like diagnostic testing and hormone therapy) other companies have built themselves on the foundation of the controversial procedure. A few years ago, a startup called The IV Doc launched with the promise of delivered-to-your-doorstep IV drips to treat symptoms of the flu, jet lag, and hangovers. It’s one of the more exclusive and expensive examples of biohacking to emerge in recent years. Throughout the industry, prices typically range from $100 to $400.

Close Up Of Iv Drip At Hospital
Getty Images

The Biostation’s B and C vitamin treatment ($149) takes about 45 minutes to complete. I would be hard pressed to say I felt noticeably more energized or rehydrated after the procedure. I did feel a tingling sensation as the infusion flowed into my veins. And I may have felt a little less hungover by the time I stood back up, but I suspect being poked by a needle is enough to make most people sober up a bit.

Shaky science

Prior to running his study, Katz hooked himself up to an IV and received his own Myer’s cocktail nutrient drip in order to get some notion of what his subjects might feel. He also doesn’t recall any drastic rush of well-being but said he could taste the influx of B vitamins. “It was a bit like a fermented sponge in the back of my mouth,” he said. “Slightly yeasty, acrid, and sour, with a bit of umami and glutamine, like you get with mushrooms.”

“Anytime there’s anything new, you’re always going to have people asking you to prove it works.”

Katz’s study, which was published in the Journal of Alternative and Complementary Medicine, found that chronic-pain patients who were given a Myers’ cocktail felt better. However, so did the patients who received a placebo.

“What little data are available would suggest that, as with so many things we do in medicine, this may make sense when it’s appropriately targeted,” Katz said. “Selective use for specific reasons in specific patients with specific outcomes in mind. But the marketing of this stuff is basically just as a pick me up, a boost, a tonic. ‘Look great, feel great.’ There’s absolutely no scientific evidence to support a benefit there.”

Katz added that, although there is conjectural reason to believe that temporarily higher nutrient levels may confer health benefits, these claims are unsubstantiated and unproven. “The problem I have with this whole space is that the marketing seems to be way out ahead of anything the science would justify,” he said.

Getty Images

Schaper concedes that there is controversy around how effective the treatment actually is, but insisted it is science-based and said her patients have reported benefits. “We go by the success stories we’ve seen in our patients who have received consistent therapy,” she said. “I don’t negate there are people who say it doesn’t work. I just don’t think it’s mainstream knowledge. Anytime there’s anything new, you’re always going to have people asking you to prove it works.”

Having tried the treatment, albeit once, I can’t personally endorse Schaper’s claim. I also don’t suffer from chronic pain. However, I have friends and acquaintances who in the past ritualistically visited their nearest nutrient drip clinic after nights of moderate to heavy drinking. For my part, even if money weren’t an issue, I’d rather endure a hangover than subject myself to a needle in the arm. I’ll stick to fresh juice and a greasy breakfast sandwich for now.

Dyllan Furness
Former Digital Trends Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
Juiced Bikes offers 20% off on all e-bikes amid signs of bankruptcy
Juiced Bikes Scrambler ebike

A “20% off sitewide” banner on top of a company’s website should normally be cause for glee among customers. Except if you’re a fan of that company’s products and its executives remain silent amid mounting signs that said company might be on the brink of bankruptcy.That’s what’s happening with Juiced Bikes, the San Diego-based maker of e-bikes.According to numerous customer reports, Juiced Bikes has completely stopped responding to customer inquiries for some time, while its website is out of stock on all products. There are also numerous testimonies of layoffs at the company.Even more worrying signs are also piling up: The company’s assets, including its existing inventory of products, is appearing as listed for sale on an auction website used by companies that go out of business.In addition, a court case has been filed in New York against parent company Juiced Inc. and Juiced Bike founder Tora Harris, according to Trellis, a state trial court legal research platform.Founded in 2009 by Harris, a U.S. high-jump Olympian, Juiced Bikes was one of the early pioneers of the direct-to-consumer e-bike brands in the U.S. market.The company’s e-bikes developed a loyal fandom through the years. Last year, Digital Trends named the Juiced Bikes Scorpion X2 as the best moped-style e-bike for 2023, citing its versatility, rich feature set, and performance.The company has so far stayed silent amid all the reports. But should its bankruptcy be confirmed, it could legitimately be attributed to the post-pandemic whiplash experienced by the e-bike industry over the past few years. The Covid-19 pandemic had led to a huge spike in demand for e-bikes just as supply chains became heavily constrained. This led to a ramp-up of e-bike production to match the high demand. But when consumer demand dropped after the pandemic, e-bike makers were left with large stock surpluses.The good news is that the downturn phase might soon be over just as the industry is experiencing a wave of mergers and acquisitions, according to a report by Houlihan Lokey.This may mean that even if Juiced Bikes is indeed going under, the brand and its products might find a buyer and show up again on streets and trails.

Read more
Volkswagen plans 8 new affordable EVs by 2027, report says
volkswagen affordable evs 2027 id 2all

Back in the early 1970s, when soaring oil prices stifled consumer demand for gas-powered vehicles, Volkswagen took a bet on a battery system that would power its first-ever electric concept vehicle, the Elektro Bus.
Now that the German automaker is facing a huge slump in sales in Europe and China, it’s again turning to affordable electric vehicles to save the day.Volkswagen brand chief Thomas Schaefer told German media that the company plans to bring eight new affordable EVs to market by 2027."We have to produce our vehicles profitably and put them on the road at affordable prices," he is quoted as saying.
One of the models will be the ID.2all hatchback, the development of which is currently being expedited to 36 months from its previous 50-month schedule. Last year, VW unveiled the ID.2all concept, promising to give it a price tag of under 25,000 euros ($27,000) for its planned release in 2025.VW CEO Larry Blume has also hinted at a sub-$22,000 EV to be released after 2025.It’s unclear which models would reach U.S. shores. Last year, VW America said it planned to release an under-$35,000 EV in the U.S. by 2027.The price of batteries is one of the main hurdles to reduced EV’s production costs and lower sale prices. VW is developing its own unified battery cell in several European plants, as well as one plant in Ontario, Canada.But in order for would-be U.S. buyers to obtain the Inflation Reduction Act's $7,500 tax credit on the purchase of an EV, the vehicle and its components, including the battery, must be produced at least in part domestically.VW already has a plant in Chattanooga, Tennesse, and is planning a new plant in South Carolina. But it’s unclear whether its new unified battery cells would be built or assembled there.

Read more
Nissan launches charging network, gives Ariya access to Tesla SuperChargers
nissan charging ariya superchargers at station

Nissan just launched a charging network that gives owners of its EVs access to 90,000 charging stations on the Electrify America, Shell Recharge, ChargePoint and EVgo networks, all via the MyNissan app.It doesn’t stop there: Later this year, Nissan Ariya vehicles will be getting a North American Charging Standard (NACS) adapter, also known as the Tesla plug. And in 2025, Nissan will be offering electric vehicles (EVs) with a NACS port, giving access to Tesla’s SuperCharger network in the U.S. and Canada.Starting in November, Nissan EV drivers can use their MyNissan app to find charging stations, see charger availability in real time, and pay for charging with a payment method set up in the app.The Nissan Leaf, however, won’t have access to the functionality since the EV’s charging connector is not compatible. Leaf owners can still find charging stations through the NissanConnectEV and Services app.Meanwhile, the Nissan Ariya, and most EVs sold in the U.S., have a Combined Charging System Combo 1 (CCS1) port, which allows access to the Tesla SuperCharger network via an adapter.Nissan is joining the ever-growing list of automakers to adopt NACS. With adapters, EVs made by General Motors, Ford, Rivian, Honda and Volvo can already access the SuperCharger network. Kia, Hyundai, Toyota, BMW, Volkswagen, and Jaguar have also signed agreements to allow access in 2025.
Nissan has not revealed whether the adapter for the Ariya will be free or come at a cost. Some companies, such as Ford, Rivian and Kia, have provided adapters for free.
With its new Nissan Energy Charge Network and access to NACS, Nissan is pretty much covering all the bases for its EV drivers in need of charging up. ChargePoint has the largest EV charging network in the U.S., with over 38,500 stations and 70,000 charging ports at the end of July. Tesla's charging network is the second largest, though not all of its charging stations are part of the SuperCharger network.

Read more